Silymarin shows potential for arthritisEfficacy and Mechanisms of , Silymarin, and Silibinin on Rheumatoid Arthritis and Osteoarthritis Symptoms: A Systematic Review.
Moderate relevance for clinical application
We explored the potential benefits of silymarin and silibinin for managing rheumatoid arthritis (RA) and osteoarthritis (OA) symptoms through a systematic review of 21 relevant studies.
The findings suggested that these compounds exhibit anti-inflammatory and antioxidant qualities, which could help protect joints from damage.
However, while the results are promising, more clinical research is necessary to confirm their effectiveness and establish guidance for their use in patients.
Read More
Silibinin shows promise in arthritisThe Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
Research relevant for autoimmune treatment
We explored the impact of silibinin, derived from silybum marianum, on immune responses related to rheumatoid arthritis. The study included both healthy individuals and patients with active arthritis to assess how silibinin affects T cell functions.
Our findings revealed that silibinin enhances ERβ expression, leading to increased apoptosis and decreased proliferation of T lymphocytes. Additionally, it reduced pro-inflammatory cytokines associated with arthritis and down-modulated miR-155, a key player in autoimmune processes.
While these results suggest that silibinin has potential as an immunosuppressive treatment tool, further research is necessary to fully understand its role in arthritis management.
Read More
We explored the potential benefits of milk thistle oil, known scientifically as Silybum marianum, in managing arthritis and providing antioxidant support. The study used oil extracted from seeds at different maturity stages and measured its effects using well-established tests for both antioxidant and anti-arthritic activities.
Our findings indicate that milk thistle oil demonstrates promising anti-arthritic properties, likely due to its policosanol content. This suggests that it could be a valuable natural alternative for people seeking relief from arthritis and related oxidative stress issues.
However, it's important to note that while results are encouraging, further research is necessary to fully understand its effectiveness and practical applications.
Read More
Silymarin reduces RA symptomsSilymarin (Livergol®) Decreases Disease Activity Score in Patients with Rheumatoid Arthritis: A Non-randomized Single-arm Clinical Trial.
Highly relevant to arthritis treatment
We examined the impact of silymarin, specifically the Livergol® tablet, on rheumatoid arthritis (RA) symptoms in a group of 44 stable patients over 90 days. Using the Disease Activity Score (DAS-28) to track changes, we found that adding silymarin to standard treatments led to a significant reduction in symptoms. The average scores dropped from 3.02 to 2.3, suggesting that silymarin may have anti-inflammatory and antioxidant benefits for RA patients. However, further research with larger samples and cytokine measurements is necessary to fully understand how it works.
Read More
We evaluated the anti-inflammatory and anti-arthritic properties of silymarin, derived from the Silybum marianum plant. In our study, we found that silymarin significantly reduced inflammation and arthritis symptoms in rat models. The research suggests that this effect occurs through the inhibition of a specific enzyme, 5-lipoxygenase.
While these results showcase the potential of silymarin, it's important to note that further research is needed to fully understand its effectiveness in humans.
Read More